Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...
Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...
Retailers' investments have ranged from strategic pivots for existing clinics to multibillion-dollar acquisitions of primary ...
The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...
The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
For over four decades, Neighborhood Family Practice has provided high-quality primary care, behavioral health services and more to Cleveland’s west side.
Thousands of cold and flu products could be on the chopping block after the FDA proposed to pull medications from store shelves that contain phenylephrine.
The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter ...
The U.S. Food and Drug Administration (FDA) announced today that it is proposing a new rule to stop the use of an ingredient ...
The FDA proposed discontinuing the use of phenylephrine, an ingredient in common medications like Sudafed, because it 'is not ...
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
T he Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold ...